Massachusetts resident Andrey Hicks has served as Partner and Fund Manager for Locust Offshore Management, L.L.C., since January of 2011. In this role, he utilizes specialized software to develop mathematical models used to create quantitative strategies and produce risk-adjusted returns with high alpha for a number of asset classes. The firm’s primary interests are in equity markets in the United States. In addition to his work with Locust Offshore Management, Andrey Hicks owns a public relations agency called By Reputation Corp., which offers customized branding and design services. He is also the founder of Niyr Design Corporation, which builds interactive online experiences for a variety of clients.
Andrey Hicks received his Bachelor of Arts in Biological Sciences from Harvard University, where he graduated summa cum laude with a 4.0 grade point average (GPA). He remained at Harvard to complete his Doctor of Philosophy in Applied Mathematics, at the School of Engineering and Applied Sciences. Andrey Hicks maintains a relationship with his alma mater through membership in the Harvard Alumni Association and the Harvard Finance Group.
Andrey Hicks won an Intel International Science and Engineering Fair (ISEF) Grand Award for a research paper on simian-human immunodeficiency virus (SHIV), entitled “Macrophages in SHIV Infection.” In addition, he co-authored another study on human immunodeficiency virus (HIV), “Neuropathogenesis of Lentiviral Infection in Macaques: Roles of CXCR4 and CCR5 Viruses and Interleukin-4 in Enhancing Monocyte Chemoattractant Protein-1 Production in Macrophages,” which was published in the peer-reviewed American Journal of Pathology.
In addition to his professional activities, Andrey Hicks donates to a number of charities. He gives to the St. Jude’s Children’s Research Hospital, which researches and treats catastrophic childhood illnesses regardless of the family’s ability to pay. Andrey Hicks also supports Special Olympics, Inc., and the Jimmy Fund, an organization founded in 1948 that supports cancer research at Boston’s Dana-Farber Cancer Institute.